{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:20:18Z","timestamp":1783092018811,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005302","name":"Alexander S Onassis Public Benefit Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20170191"],"award-info":[{"award-number":["20170191"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["H\\u00D6G2017"],"award-info":[{"award-number":["H\\u00D6G2017"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["H\\u00D6G2019"],"award-info":[{"award-number":["H\\u00D6G2019"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20190088"],"award-info":[{"award-number":["20190088"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20220083"],"award-info":[{"award-number":["20220083"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejphar.2026.178970","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:12:58Z","timestamp":1778825578000},"page":"178970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The antiplatelet activity of 6-piperazinyl-purine analogues bearing nitrate esters is determined by the length of the carbon side chain"],"prefix":"10.1016","volume":"1026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7879-7689","authenticated-orcid":false,"given":"Marianne","family":"Haug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-0462","authenticated-orcid":false,"given":"Karin","family":"Frans\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra T.","family":"Pournara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1315-1524","authenticated-orcid":false,"given":"Theano","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftichia","family":"Kritsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Ifanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva G.","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-158X","authenticated-orcid":false,"given":"Madelene","family":"Lindkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zervou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9351-8279","authenticated-orcid":false,"given":"Maria","family":"Koufaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Greneg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178970_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jth.12051","article-title":"Rho GTPases in platelet function","volume":"11","author":"Aslan","year":"2013","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2026.178970_bib2","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2026.178970_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2011.03.002","article-title":"Platelets at work in primary hemostasis","volume":"25","author":"Broos","year":"2011","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejphar.2026.178970_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jth.13302","article-title":"Platelet signaling: a complex interplay between inhibitory and activatory networks","volume":"14","author":"Bye","year":"2016","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2026.178970_bib5","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms24032519","article-title":"Rho GTPase signaling in platelet regulation and implication for antiplatelet therapies","volume":"24","author":"Dandamudi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178970_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4155\/fmc-2020-0187","article-title":"Whole blood or plasma: what is the ideal matrix for pharmacokinetic-driven drug candidate selection?","volume":"13","author":"Dash","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiol.00020.2016","article-title":"New concepts and mechanisms of platelet activation signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.ejphar.2026.178970_bib8","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1016\/j.bmc.2008.02.051","article-title":"Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents","volume":"16","author":"Fotopoulou","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216971","article-title":"Advances in metal-organic frameworks for cardiovascular therapy: from structural design to preclinical applications","volume":"544","author":"Ge","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejphar.2026.178970_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/genes14020272","article-title":"Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components","volume":"14","author":"Guan","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.ejphar.2026.178970_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64063-y","article-title":"Physiological platelet aggregation assay to mitigate drug-induced thrombocytopenia using a microphysiological system","volume":"14","author":"Harada","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178970_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178970_bib13","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1021\/acs.jmedchem.8b01098","article-title":"Identification of selective dual ROCK1 and ROCK2 inhibitors using structure-based drug design","volume":"61","author":"Hobson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejphar.2026.178970_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1074\/jbc.M508847200","article-title":"The structure of dimeric ROCK I reveals the mechanism for ligand selectivity","volume":"281","author":"Jacobs","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313079","article-title":"Current and novel antiplatelet therapies for the treatment of cardiovascular diseases","volume":"22","author":"Jourdi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178970_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","article-title":"Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin","volume":"103","author":"Kahn","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178970_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172428","article-title":"A novel purine analogue bearing nitrate ester prevents platelet activation by ROCK activity inhibition","volume":"857","author":"Kardeby","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178970_bib19","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1016\/j.bmc.2012.07.037","article-title":"Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agent","volume":"20","author":"Koufaki","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib20","doi-asserted-by":"crossref","DOI":"10.1063\/1.4972077","article-title":"A simple method for activating the platelets used in microfluidic platelet aggregation tests: Stirring-induced platelet activation","volume":"10","author":"Lee","year":"2016","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.ejphar.2026.178970_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0038-1656352","article-title":"Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation","volume":"68","author":"Lindahl","year":"1992","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.178970_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11030-021-10186-7","article-title":"Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans","volume":"25","author":"Mamada","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejphar.2026.178970_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2014.02.022","article-title":"In vitro inflammatory\/anti-inflammatory effects of nitrate esters of purines","volume":"730","author":"Maug\u00e9","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178970_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"Mueller","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178970_bib25","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V97.12.3829","article-title":"Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation","volume":"97","author":"Nieswandt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.178970_bib26","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1039\/D4MD00313F","article-title":"Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitors","volume":"15","author":"Pala","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178970_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175128","article-title":"Novel purine analogues regulate IL-1\u03b2 release via inhibition of JAK activity in human aortic smooth muscle cells","volume":"929","author":"Paramel","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178970_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202502588","article-title":"Design and synthesis of novel purine analogues as potential IL\u20101\u03b2 inhibitors targeting vascular inflammation","volume":"23","author":"Pournara","year":"2026","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejphar.2026.178970_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0035-1570082","article-title":"Platelet function determined by flow cytometry: new perspectives?","volume":"42","author":"Ramstr\u00f6m","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejphar.2026.178970_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14779072.3.3.441","article-title":"ROCKs as therapeutic targets in cardiovascular diseases","volume":"3","author":"Rikitake","year":"2005","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2026.178970_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0037-1615088","article-title":"European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function","volume":"79","author":"Schmitz","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.178970_bib32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/cvr\/cvx071","article-title":"Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets","volume":"113","author":"Sladojevic","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178970_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/14737175.2017.1395700","article-title":"ROCK as a therapeutic target for ischemic stroke","volume":"17","author":"Sladojevic","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2026.178970_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-025-02198-8","article-title":"Platelets and diseases: signal transduction and advances in targeted therapy","volume":"10","author":"Tian","year":"2025","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:48:35Z","timestamp":1783090115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S0014299926004528"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178970","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiplatelet activity of 6-piperazinyl-purine analogues bearing nitrate esters is determined by the length of the carbon side chain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178970"}}